Research Article
Improvement of Disease Management and Cost Effectiveness in Chinese Patients with Ankylosing Spondylitis Using a Smart-Phone Management System: A Prospective Cohort Study
Table 4
Comparison of baseline demographics of ankylosing spondylitis (AS) patients in observational cohort studies.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Values are expressed as mean (or median in the SCQM study) or percentage of patients. Age was defined as age at inclusion in cohort. AS: Ankylosing Spondylitis; GESPIC: German Spondyloarthritis Inception Cohort; SCQM: Swiss Clinical Quality Management Cohort; DESIR: the Devenir des spondyloarthropaties indifférenciées récentes; OASIS: the outcome in ankylosing spondylitis international study; CASPIC: Chinese Ankylosing Spondylitis Prospective Imaging Cohort; HLA: human leucocyte antigen; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; ASDAS: Ankylosing Spondylitis Disease Activity Score; CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate; BASFI: Bath Ankylosing Spondylitis Functional Index; BASMI: Bath Ankylosing Spondylitis Metrology Index; AAU: acute anterior uveitis; IBD: inflammatory bowel disease; NR: not reported; PGA: Patient’s global assessment; PhGA: Physician’s global assessment; NSAIDs: nonsteroidal anti-inflammatory drugs; TNFi: TNF inhibitors. |